These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 2487801)

  • 1. Nifedipine and hypertension: roles of vasodilation and sodium balance.
    MacGregor GA
    Cardiovasc Drugs Ther; 1989 Jun; 3 Suppl 1():295-301. PubMed ID: 2487801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nifedipine and systemic hypertension.
    MacGregor GA
    Am J Cardiol; 1989 Sep; 64(11):46F-50F. PubMed ID: 2571289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does nifedipine reveal a functional abnormality of arteriolar smooth muscle cell in essential hypertension--the effect of altering sodium balance.
    MacGregor GA; Markandu ND; Smith SJ; Sagnella GA
    J Cardiovasc Pharmacol; 1985; 7 Suppl 6():S178-81. PubMed ID: 2414584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New therapeutic approaches to arterial hypertension].
    Waeber B; Brunner HR
    Schweiz Med Wochenschr; 1982 Sep; 112(39):1330-4. PubMed ID: 6755692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Nifedipine in the treatment of hypertension].
    Guazzi M
    Rev Esp Cardiol; 1982; 35(5 Suppl 2):II23-5. PubMed ID: 7170405
    [No Abstract]   [Full Text] [Related]  

  • 6. Sodium intake, high blood pressure, and calcium channel blockers.
    MacGregor GA; Cappuccio FP; Markandu ND
    Am J Med; 1987 Mar; 82(3B):16-22. PubMed ID: 3551600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium-entry blocking agents in the treatment of systemic hypertension.
    Robinson BF
    Am J Cardiol; 1985 Jan; 55(3):102B-106B. PubMed ID: 2857516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium antagonists in the treatment of hypertension.
    Ram CV
    Am J Med Sci; 1985 Sep; 290(3):118-33. PubMed ID: 2413757
    [No Abstract]   [Full Text] [Related]  

  • 9. Nilvadipine: profile of a new calcium antagonist. An overview.
    Rosenthal J
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S92-107. PubMed ID: 7898101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Equivalent reduction of proteinuria in hypertensives by either nifedipine GITS or enalapril: disparate effects on neurohormones and ambulatory blood pressure and the influence of salt.
    DeQuattro V; Lee DP
    Cardiology; 1997; 88 Suppl 3():38-42. PubMed ID: 9397292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Calcium antagonists in the treatment of arterial hypertension].
    Raczka A
    Pol Tyg Lek; 1983 Jan; 38(3):95-7. PubMed ID: 6866828
    [No Abstract]   [Full Text] [Related]  

  • 12. Nifedipine, diuretics and sodium balance.
    MacGregor GA; Pevahouse JB; Cappuccio FP; Markandu ND
    J Hypertens Suppl; 1987 Dec; 5(4):S127-31. PubMed ID: 3481632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination drug therapy with calcium-channel blockers in the treatment of systemic hypertension.
    Frishman WH; Landau A; Cretkovic A
    J Clin Pharmacol; 1993 Aug; 33(8):752-5. PubMed ID: 8104960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study population and treatment titration in the International Nifedipine GITS Study: Intervention as a Goal in Hypertension Treatment (INSIGHT).
    Brown MJ; Castaigne A; de Leeuw PW; Mancia G; Rosenthal T; Ruilope LM
    J Hypertens; 1998 Dec; 16(12 Pt 2):2113-6. PubMed ID: 9886905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current treatment of patients with hypertension: therapeutic implications of INSIGHT.
    Taddei S; Ghiadoni L; Salvetti A
    Drugs; 2003; 63(14):1435-44. PubMed ID: 12834362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of efficacy and side effects of combination therapy of angiotensin-converting enzyme inhibitor (benazepril) with calcium antagonist (either nifedipine or amlodipine) versus high-dose calcium antagonist monotherapy for systemic hypertension.
    Messerli FH; Oparil S; Feng Z
    Am J Cardiol; 2000 Dec; 86(11):1182-7. PubMed ID: 11090788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of treatment effects with an angiotensin converting enzyme inhibitor--lisinopril and a calcium blocker--nifedipine retard on urinary albumin excretion in patients with non-complicated essential hypertension].
    Widecka K; Celibała R; Czekalski S
    Pol Arch Med Wewn; 1995 Feb; 93(2):135-42. PubMed ID: 7479231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of slow-channel calcium blocking drugs with sodium restriction, diuretics and angiotensin converting enzyme inhibitors.
    Morgan T; Anderson A
    J Hypertens Suppl; 1988 Dec; 6(4):S652-4. PubMed ID: 3241278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nifedipine activates PPARgamma and exerts antioxidative action through Cu/ZnSOD independent of blood-pressure lowering in SHRSP.
    Hashimoto R; Umemoto S; Guo F; Umeji K; Itoh S; Kishi H; Kobayashi S; Matsuzaki M
    J Atheroscler Thromb; 2010 Aug; 17(8):785-95. PubMed ID: 20460829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of acute blood pressure reduction on endothelial function in the brachial artery of patients with essential hypertension.
    Ghiadoni L; Huang Y; Magagna A; Buralli S; Taddei S; Salvetti A
    J Hypertens; 2001 Mar; 19(3 Pt 2):547-51. PubMed ID: 11327628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.